Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

22 Dec 2021 07:00

RNS Number : 4144W
Lekoil Limited
22 December 2021
 

 

 

 

22 December 2021

Lekoil Limited

("LEKOIL" or the "Company")

 

Results of Annual General Meeting

 

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa announces the results of the Company's Annual General Meeting ("AGM") held on 21 December 2021.

 

Following a vote by shareholders with a combined share capital of 258,051,201 ordinary shares representing 48.07% of the issued share capital of the Company, results on each of the resolutions put to the AGM are as set out below. Resolutions 1 to 9 were ordinary resolutions requiring a simple majority of votes cast to pass. Resolution 10 was a special resolution requiring a majority of 75% of votes cast. All resolutions put to the meeting were duly passed except for Resolution 10.

 

Resolution

Voting Result

 

For

Against

 

1. Annual Reports and Accounts

237,094,678

91.88%

20,956,223

8.12%

2. Re-election of Marco D'Attanasio

184,639,920

71.55%

73,411,281

28.45%

3. Re-election of Alphonso Tindall

185,750,125

71.98%

72,301,076

28.02%

4. Re-election of Olapade Durotoye

185,766,449

71.99%

72,284,752

28.01%

5. Re-election of Adeoye Adefulu

185,766,449

71.99%

72,284,752

28.01%

6. Electronic distribution of Annual Returns and Financial Statements

187,230,172

72.56%

70,821,029

27.44%

7. Authority of Directors to allot shares up to an aggregate number of 177,134,394

135,965,690

52.69%

122,085,511

47.31%

8. Authority of Directors to allot shares to settle accrued but unpaid fees to creditors who agree to take part or all of their fees in Relevant Securities

136,802,360

53.01%

121,248,841

46.99%

9. Authority of Directors to allot shares to the Lenders in respect of outstanding amounts under the Convertible Facility Agreement

135,965,690

52.69%

122,085,511

47.31%

10. the disapplication of shareholder pre-emption rights in respect of up to 53,667,998 shares issued for cash consideration, such disapplication to be expire at the conclusion of the next AGM

135,965,690

52.69%

122,085,511

47.31%

 

 

For further information, please visit www.lekoilplc.com or contact:

 

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

Jeff Keating / Stuart Gledhill

 

+44 20 3470 0470

 

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGZZMZZLMNGMZM
Date   Source Headline
10th Sep 20214:13 pmRNSHolding(s) in Company
10th Sep 202112:47 pmRNSDirector Loan - Update
8th Sep 202112:42 pmRNSCorporate update
2nd Sep 202112:17 pmRNSConvertible Facility Agreement
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCorporate & Operational Update
1st Sep 20214:40 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20212:05 pmRNSSecond Price Monitoring Extn
1st Sep 20212:00 pmRNSPrice Monitoring Extension
1st Sep 202111:59 amRNSHolding(s) in Company
31st Aug 20214:40 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 202111:06 amRNSSecond Price Monitoring Extn
10th Aug 202111:00 amRNSPrice Monitoring Extension
5th Jul 20214:40 pmRNSSecond Price Monitoring Extn
5th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20212:06 pmRNSSecond Price Monitoring Extn
5th Jul 20212:00 pmRNSPrice Monitoring Extension
2nd Jul 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20212:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSChange of website address
21st Jun 20213:30 pmRNSResignation of CFO
18th Jun 202112:53 pmRNSDirectorate Change
17th Jun 20217:00 amRNSDelay in publication of Annual Results for 2020
10th Jun 20217:00 amRNSCorporate Update
3rd Jun 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSAward of Options
20th Apr 20217:07 amRNSDirectorate Change
15th Apr 20218:15 amRNSDirectorate Change
26th Mar 20217:00 amRNSTrading and operational update
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20211:45 pmRNSDirector Loan - Update
26th Feb 20217:00 amRNSTR-1: notification of major holdings
24th Feb 20217:00 amRNSRe Cost and Revenue Sharing Agreement for OPL 310
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSJoint Broker Appointment
11th Jan 20217:00 amRNSAppointment of Chairman
8th Jan 202112:28 pmRNSResult of EGM
8th Jan 20217:00 amRNSRE Extraordinary General Meeting
7th Jan 20211:20 pmRNSResponse to Press Speculation
31st Dec 202012:43 pmRNSJoint Broker Resignation
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20206:05 pmRNSAppointment of Nominated Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.